#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16786	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2293	726.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	1011	C,T	939,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30464	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	840.0	0	.	n	.	0	T695C	SNP	695	695	T	1058	1058	C	894	C	832	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30464	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	840.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2001	2001	G	998	G,A	921,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30464	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	840.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2334	2334	C	989	C,T	922,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30464	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	840.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2408	2408	A	969	A	903	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30464	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	840.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2960	2960	C	889	C	837	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2458	folP	852	852	99.77	folP.l15.c4.ctg.1	1511	162.0	0	.	p	.	0	S68P	NONSYN	202	204	TCG	527	529	CCG	235;236;237	C;C;G	219;221;224	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2458	folP	852	852	99.77	folP.l15.c4.ctg.1	1511	162.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	935	937	GTA	230;233;232	G;T;A	211;211;212	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2458	folP	852	852	99.77	folP.l15.c4.ctg.1	1511	162.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1007	1009	AGC	215;211;213	A;G;C,T	202;200;199,1	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3441	179.9	1	SNP	p	S91F	1	.	.	271	273	TTC	554	556	TTC	206;204;203	T;T;C	198;193;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3441	179.9	1	SNP	p	G95N	0	.	.	283	285	GGC	566	568	GGC	206;207;204	G;G;C	188;188;183	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3441	179.9	1	SNP	p	D95G	1	.	.	283	285	GGC	566	568	GGC	206;207;204	G;G;C	188;188;183	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2018	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1293	155.5	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	244;244;247	G,A;G;C,T	227,1;229;231,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1044	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	972	106.6	0	.	n	.	0	A197.	DEL	197	197	A	585	585	A	274	A	255	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5804	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3135	184.3	1	SNP	p	D86N	0	.	.	256	258	GAC	655	657	GAC	222;225;226	G;A;C	203;199;206	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5804	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3135	184.3	1	SNP	p	R87W	0	.	.	259	261	CGT	658	660	CGT	223;222;223	C;G;T	203;201;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5804	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3135	184.3	1	SNP	p	S87R	1	.	.	259	261	CGT	658	660	CGT	223;222;223	C;G;T	203;201;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5804	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3135	184.3	1	SNP	p	R87I	0	.	.	259	261	CGT	658	660	CGT	223;222;223	C;G;T	203;201;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5804	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3135	184.3	1	SNP	p	S88P	0	.	.	262	264	TCC	661	663	TCC	224;224;227	T;C;C,G	205;202;206,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5170	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2624	195.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	264;262;261	G;G;C	247;245;245	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1291	1293	GCC	254;254;255	G;C;C	239;242;245	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1294	1296	ATG	256;253;255	A;T;G,A	245;242;242,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1306	1308	ACC	258;262;270	A;C;C	243;250;254	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1306	1308	ACC	258;262;270	A;C;C	243;250;254	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1807	1809	ACC	244;245;244	A;C;C	209;224;222	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1861	1863	GCG	239;241;241	G;C;G	228;230;229	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1861	1863	GCG	239;241;241	G;C;G	228;230;229	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1984	1986	GGT	196;197;195	G;G;T	179;181;179	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1993	1995	AGC	181;179;178	A,T;G,T;C	168,1;166,1;164	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4662	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	189.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2011	2013	CCG	163;165;168	C,G,T;CG,CGGG;G	112,9,1;111,1;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6558	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3150	207.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1718	1720	CCG	250;249;252	C;C;G	207;218;216	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3032	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1746	172.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	505	505	C	211	C	191	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3300	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1701	193.1	1	SNP	p	G120K	1	.	.	358	360	AAG	684	686	AAG	312;312;310	A;A;G	282;285;279	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3300	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1701	193.1	1	SNP	p	N121D	0	.	.	361	363	AAC	687	689	AAC	313;311;310	A,G;A;C	284,1;284;282	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3300	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1701	193.1	1	SNP	p	A121N	1	.	.	361	363	AAC	687	689	AAC	313;311;310	A,G;A;C	284,1;284;282	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11566	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4747	242.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1258	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1073	116.6	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	260;261;258	A;T;G	248;248;247	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
